Vulinacimab (HLX-06) is a monoclonal antibody targeting VEGFR-2, a receptor overexpressed in various tumor types. This antibody is instrumental in studying the mechanisms of angiogenesis and the associated processes of proliferation, survival, migration, and differentiation of endothelial cells in cancer research. Vulinacimab provides a valuable tool for investigating the role of VEGFR-2 in oncological pathologies and therapeutic interventions.
Vulinacimab (HLX-06) is a monoclonal antibody targeting VEGFR-2, a receptor overexpressed in various tumor types. This antibody is instrumental in studying the mechanisms of angiogenesis and the associated processes of proliferation, survival, migration, and differentiation of endothelial cells in cancer research. Vulinacimab provides a valuable tool for investigating the role of VEGFR-2 in oncological pathologies and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
